Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 291, Issue 3, 2006, Pages

  Gosens, Reinoud ^a,b,c   Stelmack, Gerald L ^a,b   Dueck, Gordon ^a,b   McNeill, Karol D ^a,b   Yamasaki, Akira ^a,b   Gerthoffer, William T ^d   Unruh, Helmut ^a   Gounni, Abdelilah Soussi ^a   Zaagsma, Johan ^c   Halayko, Andrew J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Airway remodeling; Airway smooth muscle phenotype; Asthma; Hyperplasia; Platelet derived growth factor receptor

Indexed keywords

CAVEOLIN 1; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSFER RNA;

ARTICLE; ASTHMA; CAVEOLA; CELL LINE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MUSCLE CELL; MUSCLE MASS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER;

CAVEOLAE; CAVEOLIN 1; CELL LINE; CELL PROLIFERATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE CELLS; MUSCLE, SMOOTH; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; TELOMERASE;

EID: 33748421657     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00013.2006     Document Type: Article

References (54)

1. Abulrob A, Giuseppin S, Andrade MF, McDermid A, Moreno M, and Stanimirovic D. Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae. Oncogene 23: 6967-6979, 2004.
2. Bergdahl A and Sward K. Caveolae-associated signalling in smooth muscle. Can J Physiol Pharmacol 82: 289-299, 2004.
3. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, and Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998.
4. Cho WJ and Daniel EE. Colocalization between caveolin isoforms in the intestinal smooth muscle and interstitial cells of Cajal of the Cav1(+/+) and Cav1(-/-) mouse. Histochem Cell Biol 1-8, 2005.
5. Citro S, Ravasi S, Rovati GE, and Capra V. Thromboxane prostanoid receptor signals through Gi protein to rapidly activate extracellular signal-regulated kinase in human airways. Am J Respir Cell Mol Biol 32: 326-333, 2005.
6. Cohen AW, Hnasko R, Schubert W, and Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379, 2004.
7. Condon J, Yin S, Mayhew B, Word RA, Wright WE, Shay JW, and Rainey WE. Telomerase immortalization of human myometrial cells. Biol Reprod 67: 506-514, 2002.
8. 2+ handling. Am J Physiol Lung Cell Mol Physiol 279: L1226-L1235, 2000.
9. Foster LJ, De Hoog CL, and Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 100: 5813-5818, 2003.
10. Fujita Y, Maruyama S, Kogo H, Matsuo S, and Fujimoto T. Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int 66: 1794-1804, 2004.
11. Furuchi T and Anderson RG. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 273: 21099-21104, 1998.
12. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG, and Lisanti MP. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 12: 2229-2244, 2001.
13. Gerthoffer WT, Pari GS, and Wysolmerski RB. Immortalized human airway smooth muscle cells with a contractile phenotype (Abstract). Am J Respir Crit Care Med 169: A188, 2004.
14. Gosens R, Meurs H, Bromhaar MM, McKay S, Nelemans SA, and Zaagsma J. Functional characterization of serum- and growth factor-induced phenotypic changes in intact bovine tracheal smooth muscle. Br J Pharmacol 137: 459-466, 2002.
15. Gosens R, Nelemans SA, Hiemstra M, Grootte Bromhaar MM, Meurs H, and Zaagsma J. Insulin induces a hypercontractile airway smooth muscle phenotype. Eur J Pharmacol 481: 125-131, 2003.
16. Hailstones D, Sleer LS, Parton RG, and Stanley KK. Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res 39:369-379, 1998.
17. Halayko AJ, Salari H, Ma X, and Stephens NL. Markers of airway smooth muscle cell phenotype. Am J Physiol Lung Cell Mol Physiol 270: L1040-L1051, 1996.
18. Halayko AJ, Camoretti-Mercado B, Forsythe SM, Vieira JE, Mitchell RW, Wylam ME, Hershenson MB, and Solway J. Divergent differentiation paths in airway smooth muscle culture: induction of functionally contractile myocytes. Am J Physiol Lung Cell Mol Physiol 276: L197-L206, 1999.
19. Halayko AJ, Kartha S, Stelmack GL, McConville J, Tam J, Camoretti-Mercado B, Forsythe SM, Hershenson MB, and Solway J. Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am J Respir Cell Mol Biol 31: 266-275, 2004.
20. Halayko AJ, Stelmack GL, Yamasaki A, McNeill K, Unruh H, and Rector E. Distribution of phenotypically disparate myocyte subpopulations in airway smooth muscle. Can J Physiol Pharmacol 83: 104-116, 2005.
21. Hays SR, Ferrando RE, Carter R, Wong HH, and Woodruff PG. Structural changes to airway smooth muscle in cystic fibrosis. Thorax 60: 226-228, 2005.
22. Hirst SJ, Barnes PJ, and Twort CH. PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 270: L415-L428, 1996.
23. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164: S28-S38, 2001.
24. Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G, Burgess JK, and Black JL. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 164: 474-477, 2001.
25. Kelleher MD, Abe MK, Chao TS, Jain M, Green JM, Solway J, Rosner MR, and Hershenson MB. Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis. Am J Physiol Lung Cell Mol Physiol 268: L894-L901, 1995.
26. Kilsdonk EP, Yancey PG, Stoudt GW, Bangerter FW, Johnson WJ, Phillips MC, and Rothblat GH. Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem 270: 17250-17256, 1995.
27. Kuo KH, Herrera AM, and Seow CY. Ultrastructure of airway smooth muscle. Respir Physiol Neurobiol 137: 197-208, 2003.
28. Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, and Lisanti MP. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol 14: 1750-1775, 2000.
29. Liu P, Ying Y, Ko YG, and Anderson RG. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 271: 10299-10303, 1996.
30. Liu P, Ying Y, and Anderson RG. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc Natl Acad Sci USA 94: 13666-13670, 1997.
31. Ma X, Wang Y, and Stephens NL. Serum deprivation induces a unique hypercontractile phenotype of cultured smooth muscle cells. Am J Physiol Cell Physiol 274: C1206-C1214, 1998.
32. McKee JA, Banik SS, Boyer MJ, Hamad NM, Lawson JH, Niklason LE, and Counter CM. Human arteries engineered in vitro. EMBO Rep 4: 633-638, 2003.
33. Mihara K, Imai C, Coustan-Smith E, Dome JS, Dominici M, Vanin E, and Campana D. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol 120: 846-849, 2003.
34. Moir LM, Ward JP, and Hirst SJ. Contractility and phenotype of human bronchiole smooth muscle after prolonged fetal bovine serum exposure. Exp Lung Res 29: 339-359, 2003.
35. Naureckas ET, Ndukwu IM, Halayko AJ, Maxwell C, Hershenson MB, and Solway J. Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle. Am J Respir Crit Care Med 160: 2062-2066, 1999.
36. Okamoto T, Schlegel A, Scherer PE, and Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
37. Orsini MJ, Krymskaya VP, Eszterhas AJ, Benovic JL, Panettieri RA Jr, and Penn RB. MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. Am J Physiol Lung Cell Mol Physiol 277: L479-L488, 1999.
38. Ostrom RS and Insel PA. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 143: 235-245, 2004.
39. Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M, Sowa G, Gores GJ, Sessa WC, and Simari RD. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 23: 1521-1527, 2003.
40. Pike LJ. Lipid rafts: heterogeneity on the high seas. Biochem J 378: 281-292, 2004.
41. Rahman MS, Yang J, Shan LY, Unruh H, Yang X, Halayko AJ, and Gounni AS. IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism. Clin Immunol 115: 268-276, 2005.
42. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, and Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
43. Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H Jr,. Christ GJ, Edelmann W, and Lisanti MP. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22: 2329-2344, 2002.
44. Razani B, Woodman SE, and Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
45. Schwencke C, Schmeisser A, Walter C, Wachter R, Pannach S, Weck B, Braun-Dullaeus RC, Kasper M, and Strasser RH. Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis. Cardiovasc Res 68: 128-135, 2005.
46. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, and Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19: 7289-7304, 1999.
47. Stehr M, Adam RM, Khoury J, Zhuang L, Solomon KR, Peters CA, and Freeman MR. Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder smooth muscle cells: dependence on lipid rafts for cell signaling. J Urol 169: 1165-1170, 2003.
48. Thyberg J, Roy J, Tran PK, Blomgren K, Dumitrescu A, and Hedin U. Expression of caveolae on the surface of rat arterial smooth muscle cells is dependent on the phenotypic state of the cells. Lab Invest 77: 93-101, 1997.
49. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, and Alexander RW. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 276: 48269-48275, 2001.
50. Wang PY, Weng J, and Anderson RG. OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science 307: 1472-1476, 2005.
51. Woodruff PG, Dolganov GM, Ferrando RE, Donnelly S, Hays SR, Solberg OD, Carter R, Wong HH, Cadbury PS, and Fahy JV. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 169: 1001-1006, 2004.
52. Xu C, Jiang J, Sottile V, McWhir J, Lebkowski J, and Carpenter MK. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22: 972-980, 2004.
53. Yamamoto M, Toya Y, Jensen RA, and Ishikawa Y. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp Cell Res 247: 380-388, 1999.
54. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu CP, and Herron GS. Human endothelial cell life extension by telomerase expression. J Biol Chem 274: 26141-26148, 1999.